St. Louis, Missouri STL
Loading…
Oldest neighborhood newspaper in St. Louis · Independent and all volunteer-run since 1970

COVID Vaccine Information For Seniors With No Internet Or Email Access

Historical April–May 2021 article. Dates, prices, services and contacts describe the source period; current availability has not been established.

The City’s St. Louis Area Agency on Aging (SLAAA) is working to assist the City Health Dept., to help Seniors Citizens get registered to receive the COVID-19 Vaccine. Senior Citizens who have access to the internet and have an email address of their own, can register for the vaccine themselves on the Health Dept. vaccine website.

However, SLAAA is working to help Seniors who DO NOT have access to the Internet and DO NOT have an email address. Senior Citizens can call the City SLAAA office at 314-612- 5918.

There is a very large call volume, so Callers should expect to be placed on HOLD on the phone line or callers can leave a phone number and they will receive a call back. SLAAA staff will help to: 1. Complete the COVID-19 Registration in the Health Dept. online system, which will notify the Health Dept. that the Senior is interested in getting the vaccine when it becomes available. 2.

When the Health Dept. receives the vaccines for distribution….the Health Dept. will inform SLAAA of the dates of Vaccine Distribution Events. SLAAA staff will call the Seniors that SLAAA has registered, to set up an appointment for the Seniors to receive the vaccines. 3.

If the Senior Citizen is Homebound and/ or has no access to transportation, SLAAA will coordinate with the Senior Citizen Centers that have Vans, so that transportation can be arranged to take the Senior to the vaccine appointment location (round trip) at no cost to the Senior (funding is limited for this transportation service).

Originally published in The Times of Skinker-DeBaliviere, April–May 2021.

Read this article in the original newspaper issue.

Original source: SD_Times2021_04.pdf, printed page(s) 1; PDF page(s) 1.

COVID-19